EMBARC has made all of the information about the design and conduct of the European Bronchiectasis Registry publically available through a new publication in The European Respiratory Journal Open …

EMBARC seeks to encourage applications to the ERS fellowship programme in the exciting field of bronchiectasis research. The European Respiratory Society provides fellowships to support young …

View two presentations from the European Respiratory Society congress, including the first results from the EMBARC registry in our round-up of the ERS 2015 highlights and the EMBARC symposium - www. …

The first results of the EMBARC registry were announced at the beginning of October at the ERS congress in Amsterdam. Thanks to the dedication of all of the clinicians, nurses and allied health …

The ERS congress has started with a number of contributions on bronchiectasis from researchers from EMBARC and partners. We are delighted to see so many participants at the oral presentation and …

At Congress, the Healthy Lungs for Life campaign will launch its new theme: Take the Active Option. We think this campaign offers a great opportunity to raise awareness of the role of physical …

EMBARC is contributing to a €50 million, Europe-wide, project to develop new drugs that could improve the lives of patients with cystic fibrosis and bronchiectasis.

The iABC (inhaled …

EMBARC will be working hard to promote bronchiectasis at the upcoming ERS congress in Amsterdam. Learn more about EMBARC and get involved in the project at Congress.

Visit the EMBARC stand in the …

A new Cochrane review on the effectiveness of prolonged antibiotics was published today

The review highlighted the paucity of data in bronchiectasis, identifying few trials and only 1157 patients …

The European Respiratory Society Congress in Amsterdam is showcases a wealth of information on all aspects of respiratory health and disease. We are delighted that the first results of the European …